GenVec discontinues trials of experimental cancer drug; stock plunges - Washington Post
GenVec discontinues trials of experimental cancer drug; stock plungesWashington Post"We were hopeful that we were going to buck that trend," Fischer said, "but pancreatic cancer seems to have gotten another victim here. ...GenVec shares plunge after cancer drug trial discontinuedReutersGenVec stock plummets as biotech stops cancer drug trialBusiness GazetteGeneVec's Pancreatic cancer Therapy CrashesCorante (blog)FierceBiotech�-RTT News�-Washington Business Journalall 86 news articles��
Blog Content
Post a Comment